Z-ATAD-FMK,Caspase-12抑制剂(ab141383)
Key features and details
- Caspase-12 inhibitor
- CAS Number:
- Purity: > 95%
- Soluble in DMSO to 20 mM
- Form / State: Lyophilized
- Source: Synthetic
概述
-
产品名称
Z-ATAD-FMK,Caspase-12抑制剂 -
描述
Caspase-12抑制剂 -
纯度
> 95% -
常规说明
This product is manufactured by BioVision, an Abcam company and was previously called 1152 ATAD-FMK, Z-,. 1152-5 is the same size as the 5 mg size of ab141383.
-
化学结构
性能
-
分子量
540.54 -
分子式
C24H33N4O9F -
序列
ATAD (Modifications: N-terminal benzyloxycarbonyl; C-terminal FMK; Asp-4 = Asp(OMe)) -
存放说明
Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months. -
溶解度概述
Soluble in DMSO to 20 mM -
处理
Wherever possible, you should prepare and use solutions on the same day. However, if you need to make up stock solutions in advance, we recommend that you store the solution as aliquots in tightly sealed vials at -20°C. Generally, these will be useable for up to one week. Before use, and prior to opening the vial we recommend that you allow your product to equilibrate to room temperature for at least 1 hour.
Need more advice on solubility, usage and handling? Please visit our frequently asked questions (FAQ) page for more details.
-
来源
Synthetic
-
研究领域
相关产品
-
Related Products
实验方案
To our knowledge, customised protocols are not required for this product. Please try the standard protocols listed below and let us know how you get on.
数据表及文件
-
SDS download
-
Datasheet download
文献 (2)
ab141383 被引用在 2 文献中.
- Han J et al. Myricetin activates the Caspase-3/GSDME pathway via ER stress induction of pyroptosis in lung cancer cells. Front Pharmacol 13:959938 (2022). PubMed: 36091790
- Wang J et al. Fundc1-dependent mitophagy is obligatory to ischemic preconditioning-conferred renoprotection in ischemic AKI via suppression of Drp1-mediated mitochondrial fission. Redox Biol 30:101415 (2020). PubMed: 31901590